Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News AtriCure Inc ATRC

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze... see more

Recent & Breaking News (NDAQ:ATRC)

AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management

Business Wire 8 days ago

AtriCure to Announce First Quarter 2024 Financial Results

Business Wire April 10, 2024

AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Business Wire March 26, 2024

AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results

Business Wire February 15, 2024

AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference

Business Wire January 25, 2024

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024

Business Wire January 8, 2024

AtriCure Appoints Shlomi Nachman to the Board of Directors

Business Wire January 4, 2024

AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire December 20, 2023

AtriCure to Participate in the Piper Sandler 35th Annual Healthcare Conference

Business Wire November 15, 2023

AtriCure Releases 2023 ESG Report

Business Wire November 14, 2023

AtriCure Reports Third Quarter 2023 Financial Results

Business Wire November 1, 2023

AtriCure to Participate in the Stifel 2023 Healthcare Conference

Business Wire October 31, 2023

AtriCure Reports Second Quarter 2023 Financial Results

Business Wire July 25, 2023

AtriCure to Participate at Upcoming Investor Conferences

Business Wire July 21, 2023

AtriCure to Announce Second Quarter 2023 Financial Results

Business Wire July 3, 2023

AtriCure Reports First Quarter 2023 Financial Results

Business Wire May 2, 2023

AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast

Business Wire April 19, 2023

AtriCure to Announce First Quarter 2023 Financial Results

Business Wire April 11, 2023

AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Business Wire April 3, 2023

AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results

Business Wire February 21, 2023